Our team work in diverse disciplines, from basic biology and chemistry through to clinical trials and surgery to translate scientific discovery to patient care in the clinic.
Within the GPOL team there is significant expertise encompassing basic science, histopathology, drug development, bioinformatics, translational techniques, quality assurance and clinical trials management.
Dr Philip Beer is a physician scientist with expertise in clinical cancer genomics, early phase therapeutic development and biomarker discovery.
Dr David Chang is Chief Investigator of the Precision-Panc Master Protocol and its first 3 associated PRIMUS clinical trials. David specialises in the treatment of malignant pancreatic diseases and his research focus is on the development and implementation of novel therapeutic strategies.
Dr Nigel Jamieson is a surgeon-scientist and Clinical Lead of the Clinical Implementation group.
We are looking for highly motivated and innovative individuals to join our team of pioneering researchers.Join The Team